HSA — authorised 18 March 2022
- Marketing authorisation holder: MARINUS PHARMA INC
- Status: likely_approved
HSA authorised Ztalmy on 18 March 2022
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. HSA authorised it on 18 March 2022.
MARINUS PHARMA INC holds the Singaporean marketing authorisation.